Image For Activity Cover
Virtual Tumor Board: HPB - December 2022
Hepatic Artery Infusion: What is the role in metastatic and primary liver disease?
Activity Overview

This case-based discussion will focus on HAI pump use in non-resectable CRLM, as adjuvant therapy following resection, and in intra-hepatic cholangiocarcinoma. 

Moderating this session will be:

Alexander A. Parikh, MD, MPH, FACS, FSSO, UT Health San Antonio MD Anderson
Miral S. Grandhi, MD, FACS, Rutgers Cancer Institute of New Jersey


Michael Lidsky, MD, FACS, Duke University Medical Center

Paul Karanicolas, MD, PhD, FRCS(C), FACS, Sunnybrook Health Sciences Centre, University of Toronto
Andrea Cercek, MD, Memorial Sloan Kettering Cancer Center

Learning Objectives
  1. To better understand the role of hepatic artery infusion in the treatment of non-resectable colorectal liver metastases.
  2. To understand the utility of hepatic artery infusion in the adjuvant setting for resectable colorectal liver metastases
  3. To become familiar with the role of hepatic artery infusion in other tumor types including cholangiocarcinoma
Availability: No future session
Cost: FREE
Credit Offered:
No Credit Offered
Powered By